Grant winners - 27 November 2014

十一月 27, 2014

Engineering and Physical Sciences Research Council/Royal Society

Royal Society-EPSRC Dorothy Hodgkin Fellows

This scheme supports outstanding scientists and engineers at an early stage of their career and is designed to help them progress to permanent academic positions. These are funded by the EPSRC

Virtual calculus


Long-range interactions and collective dissipation in ultracold atomic lattices

 

National Institute for Health Research

Public Health Research Programme

Fuelling health equity? The impact of the winter fuel payment on the health of UK households


The effectiveness and cost-effectiveness of an employer-led intervention to increase walking during the daily commute: cluster randomised controlled trial


Understanding the impact of tobacco tax increases and tobacco industry pricing on smoking behaviours and inequalities


Efficacy and Mechanism Evaluation Programme

Platelet-rich plasma (PRP) in Achilles tendon rupture (ATR) healing


Optimal utilisation of biologic drugs in Behçet’s disease: a randomised controlled trial of infliximab vs alpha interferon, with genotyping and metabolomic profiling, towards a stratified medicines approach to treatment

 

Biotechnology and Biological Sciences Research Council

Research Grants

Transgenerational immune priming in plants


Training Grants

Identifying the molecular basis for regulatory T cell-induced anti-inflammatory function of monocytes and macrophages

In detail

Wellcome Trust/Department for International Development

Award winner: Sterghios Moschos
Institution: University of Westminster
Value: £620,000

EbolaCheck

Researchers aim to develop a portable device that can test bodily fluids such as saliva for the presence of the Ebola virus and give results within 40 minutes, more than eight times faster than some lab techniques. Leading the project is the University of Westminster’s Sterghios Moschos, director of its Genomic Services Unit, working with Edward Wright, an Ebola expert and senior lecturer in medical microbiology. The team hope to have an inexpensive, battery-powered portable EbolaCheck device ready for use in the field by next May. “We will use robust technologies to develop a simple but effective tool to diagnose this deadly virus [that is] similar to a blood glucose meter and as reliable as hospital tests,” Dr Moschos said. EbolaCheck will use a technology provided by a Cambridge-based biotech firm on humanitarian grounds.

Times Higher Education free 30-day trial

请先注册再继续

为何要注册?

  • 注册是免费的,而且十分便捷
  • 注册成功后,您每月可免费阅读3篇文章
  • 订阅我们的邮件
注册
Please 登录 or 注册 to read this article.